Co-enrollment of critically ill patients into multiple studies: Patterns, predictors and consequences

Deborah Cook, Ellen McDonald, Orla Smith, Nicole Zytaruk, Diane Heels-Ansdell, Irene Watpool, Tracy McArdle, Andrea Matte, France Clarke, Shirley Vallance, Simon Finfer, Pauline Galt, Tim Crozier, Rob Fowler, Yaseen Arabi, Clive Woolfe, Neil Orford, Richard Hall, Neill K.J. Adhikari, Marie Clauide FerlandJohn Marshall, Maureen Meade

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Abstract

Introduction: Research on co-enrollment practices and their impact are limited in the ICU setting. The objectives of this study were: 1) to describe patterns and predictors of co-enrollment of patients in a thromboprophylaxis trial, and 2) to examine the consequences of co-enrollment on clinical and trial outcomes.Methods: In an observational analysis of an international thromboprophylaxis trial in 67 ICUs, we examined the co-enrollment of critically ill medical-surgical patients into more than one study, and examined the clinical and trial outcomes among co-enrolled and non-co-enrolled patients.Results: Among 3,746 patients enrolled in PROTECT (Prophylaxis for ThromboEmbolism in Critical Care Trial), 713 (19.0%) were co-enrolled in at least one other study (53.6% in a randomized trial, 37.0% in an observational study and 9.4% in both). Six factors independently associated with co-enrollment (all P < 0.001) were illness severity (odds ratio (OR) 1.35, 95% confidence interval (CI) 1.19 to 1.53 for each 10-point Acute Physiology and Chronic Health Evaluation (APACHE) II score increase), substitute decision-makers providing consent, rather than patients (OR 3.31, 2.03 to 5.41), experience of persons inviting consent (OR 2.67, 1.74 to 4.11 for persons with > 10 years' experience compared to persons with none), center size (all ORs > 10 for ICUs with > 15 beds), affiliation with trials groups (OR 5.59, 3.49 to 8.95), and main trial rather than pilot phase (all ORs > 8 for recruitment year beyond the pilot). Co-enrollment did not influence clinical or trial outcomes or risk of adverse events.Conclusions: Co-enrollment was strongly associated with features of the patients, research personnel, setting and study. Co-enrollment had no impact on trial results, and appeared safe, acceptable and feasible. Transparent reporting, scholarly discourse, ethical analysis and further research are needed on the complex topic of co-enrollment during critical illness.

Original languageEnglish
Article numberR1
JournalCritical Care
Volume17
Issue number1
DOIs
Publication statusPublished - Jan 8 2013

Bibliographical note

Funding Information:
This study was funded by a North American Meeting Grant of the Canadian Institutes for Health Research which had no role in the design, conduct, analysis, interpretation or write-up of this report. D Cook, N Zytaruk and D Heels-Ansdell had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. We appreciate the interest of family members and patients in research, which enabled the main trial and this study. We thank research coordinators and physicians from all participating PROTECT centers for their collaboration. We are grateful to the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group and all participating centers for their engagement. D Cook is a Research Chair of the Canadian Institutes for Health Research. R Fowler is a Clinician Scientist of the Heart and Stroke Foundation of Canada. M Meade is an RCT Mentor of the Canadian Institutes for Health Research. We thank L Hand, K Porretta, C Wynne, D Foster and P Farias for helpful comments on earlier drafts. PROTECT Collaborators Clinical Collaborators Canadian Investigators  Dr Deborah Cook (Lead), Ellen McDonald, Andrea Tkaczyk, France Clarke; Pharmacist: Christine Wallace; St Joseph’s Healthcare, Hamilton  Drs Rick Hall and Graeme Rocker, Lisa Julien, Debbie Wright, Caroline Roy, Judy Theriault, Susan Pleasance; Pharmacy Technicians: Debi Snow and Shannon Herbert; Capital Health Queen Elizabeth II Health Science Center, Halifax  Dr Maureen Meade, Lori Hand; Pharmacy Technician: Maya Biljan; Hamilton Health Sciences, Hamilton General Hospital, Hamilton  Dr Andreas Freitag, Christine Wynne, Mark Duffett, Michelle Kho, Nicole Zytaruk; Pharmacy Technician: Karen Currie; Hamilton Health Sciences, McMaster Hospital, Hamilton  Dr John Granton, Andrea Matte, Paulina Farias, Leslie Chu, Nancy Brockest, Stephanie Go, Margaret McGrath-Chong, Madison Dennis, Marc Lipkus, Emily Stern, Ryan Albert; Pharmacy: Ron Seto, Muhammad Zuberi, Jie Ming and Laura Arus-Pampin, Muhammad Walid, Robert Solek, Kim De freitas; University Health Network, Toronto General Hospital, Toronto  Drs Stephan Langevin, François Lauzier and Alexis F Turgeon, Martine Blais, Maxime Beauparlant, Julie Asselin, Caroline Roy, Chantal Gagné, Marie Thibodeau; Pharmacists: Anik Rioux and Tuong-Vi Tran; Hôpital de l’Enfant-Jésus, Quebec City  Dr Germain Poirier, Isabelle Neas, Sandrine Spearson; Pharmacist: Betty Ton; Charles Hôpital Charles-LeMoyne, Longueuil  Drs Lauralyn McIntyre and Paul Hébert, Irene Watpool, Tracy McArdle, Claude Gaudert, Paule Marchand, Carson Davidson; Pharmacists: Anne-Marie Dugal and Susan Fetzer; Ottawa Hospital, General Campus, Ottawa  Dr Joe Pagliarello, Mary-Jo Lewis, Erin Murphy, Julia Foxall; Pharmacist: Sherry Weir; Ottawa Hospital Civic Campus, Ottawa  Dr Yoanna Skrobik, Johanne Harvey, Stefania Chitu; Pharmacists: Marceline Quach and Linda Pinet; Hôpital Maisonneuve-Rosemont, Montréal  Dr Martin Albert, Carole Sirois, Carole Nadon, Stéphanie Dolle, Audrey-Anne Gosselin, Patrice Deroy; Pharmacists: Anne Julie Frenette and David Williamson; Hôpital du Sacré-Coeur de Montréal, Montréal  Dr Sangeeta Mehta, Cheryl Ethier, Sam Tirgari, Lindsay Steinberg, Rod McDonald, Vidhya Sivanantham, Kristofer Bandayrel, Friederike Quittnat Pelletier, Marnie Kramer-Kile, Maedean Brown, Scott Kim; Pharmacist Holly Leung; Mount Sinai Hospital, Toronto  Dr Robert Fowler, Nicole Marinoff, Karen Code, Boris Bojilov, Derek Parsotam; Pharmacist: John Iazzetta; Sunnybrook Hospital, Toronto  Dr John Marshall, Orla Smith, Beth Fry, Kerri Porretta, Yoon Lee, Jeanna Morrissey, Victoria Wen; Pharmacy Technicians: Laura Parsons and Ann Kosinski; St Michael’s Hospital, Toronto  Dr John Muscedere, Susan Fleury, Nicole Godfrey, Sharlene Hammond, Elizabeth Mann, Monica Myers, Amber Robinson; Pharmacist: Chris Grey; Kingston General Hospital, Kingston  Drs Sean Keenan and Steven Reynolds, Miroslav Svetik, Mary Van Osch; Pharmacist: Anne-Marie Liberman; Royal Columbian Hospital, Westminster  Drs Dean Chittock and Vinay Dhingra, Maureen Gardner, Susan Logie, Denise Foster, Roger Autio, Dara Davies, Pia Ganz, Laurie Smith; Pharmacy: Jane Day, Kaldip Mattu and Judy Yip; Vancouver General Hospital, Vancouver  Dr Peter Dodek, Betty Jean Ashley, Sheilagh Mans; Pharmacist: Mara Pavan; St. Paul’s Hospital, Vancouver  Dr Chip Doig, Linda Knox, Crystal Wilson, Kevin Champagne; Pharmacist: Angela Kayall Peters; Calgary University Foothills Hospital, Calgary  Dr Niall Ferguson, Andrea Matte, James Stevenson, Joel Elman, Madison Dennis; Pharmacist: Jenn Tung, Robert Solek, Kim De Freitas, Nga Pham; University Health Network, Toronto Western Hospital, Toronto  Dr Jim Kutsogiannis, Patrica Thompson, Norine Whalen; Pharmacist: Liz Helboe; Royal Alexandra Hospital, Edmonton  Dr François Lellouche, Marie-Claude Ferland, Patrick Dussault, Caroline Jacob, Marie-Ève Morneau, Nancy Laberge; Pharmacist: Nathalie Chateauvert; Institut Universtaire de Cardiologie et de Pneumologie de Québec, Québec  Dr Tim Karachi, Andrea Tkaczyk; Pharmacy Technician: Diane Lourenco; Hamilton Health Sciences, Juravinski Hospital, Hamilton  Dr Michael Jacka, Marleen Irwin, Carmen Chan, Leeca Sonnema, Kelly Marsh, Jennifer Maurer, Tamara Kreidl, Candice Varden, Carey Kinjerski; Pharmacist: Noelle Carey; University of Alberta, Edmonton  Dr Chip Doig, Linda Knox, Crystal Wilson, Kevin Champagne; Pharmacist: Angela Kayall Peters; Calgary University Peter Lougheed Hospital, Calgary  Dr Kosar Khwaja, Laura Banici, Carole Sirois, Lena Havell; Pharmacists: Gilbert Matte and Kathleen Normandin; Montreal General Hospital, Montréal  Dr Gordon Wood, Fiona Auld, Leslie Atkins; Pharmacist: John Foster-Coull; Vancouver Island Health Authority, Vancouver  Drs Olivier Lesur and François Lamontagne, Sandra Proulx; Pharmacist: Sylvie Cloutier, Brigitte Bolduc, Marie-Pierre Rousseau, Julie Leblond; Centre Hospitalier Universitaire de Sherbrooke and Centre de Recherche Clinique Étienne-Le Bel, Sherbrooke  Dr Kosar Khwaja, Laura Banici, Carole Sirois, Lena Havell; Pharmacists: Gilbert Matte and Kathleen Normandin; Royal Victoria Hospital, Montreal

ASJC Scopus Subject Areas

  • Critical Care and Intensive Care Medicine

Fingerprint

Dive into the research topics of 'Co-enrollment of critically ill patients into multiple studies: Patterns, predictors and consequences'. Together they form a unique fingerprint.

Cite this